Importantly, the treatment of STZ-induced type I diabetic mice with the A2AR antagonist by intravitreal injection was initiated 4 weeks after the onset of diabetes, when the retina is already compromised6,29,38. This evidence concerns the gene ADORA2A and diabetes mellitus.